19.02.2013 Views

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>CMS</strong>-1403-FC<br />

costs that should be included in the calculation of “net<br />

charge” are those directly paid to the pathologist<br />

performing the PC or supervising the TC and should be<br />

limited to the W-2 salary income of the pathologist, not<br />

including any bonus.<br />

Response: After considering the issue further, we<br />

decline at this time to make any changes to what we allow<br />

to be included in the calculation of “net charge.” As we<br />

stated in the preamble to the CY 2008 PFS final rule (72 FR<br />

66319 through 66320), we are concerned that, allowing<br />

billing physicians and other suppliers to recoup costs such<br />

as overhead in situations in which the anti-markup<br />

provisions apply, would undermine a purpose of the anti-<br />

markup payment limitation because the incentive to<br />

overutilize (to recover capital outlays and other costs)<br />

would still be present. Therefore, where the billing<br />

physician or other supplier pays the performing supplier a<br />

fixed fee for the TC or the PC, the “net charge” is the<br />

fixed fee (exclusive of any charge that is intended to<br />

reflect the cost of equipment or space leased to the<br />

performing supplier by or through the billing physician or<br />

other supplier, per §414.50(a)(2)(i)). Where a fixed fee<br />

is not paid, the billing physician or other supplier is<br />

limited to the salary and benefits it paid to the<br />

504

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!